A detailed history of Donoghue Forlines LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Donoghue Forlines LLC holds 4,200 shares of JNJ stock, worth $658,266. This represents 0.18% of its overall portfolio holdings.

Number of Shares
4,200
Previous 12,082 65.24%
Holding current value
$658,266
Previous $1.91 Million 67.92%
% of portfolio
0.18%
Previous 0.57%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$144.38 - $157.78 $1.14 Million - $1.24 Million
-7,882 Reduced 65.24%
4,200 $613,000
Q1 2024

May 07, 2024

BUY
$155.22 - $162.74 $393,948 - $413,034
2,538 Added 26.59%
12,082 $1.91 Million
Q4 2023

Feb 07, 2024

SELL
$145.6 - $158.88 $124,633 - $136,001
-856 Reduced 8.23%
9,544 $1.5 Million
Q3 2023

Nov 06, 2023

BUY
$155.75 - $174.48 $351,683 - $393,975
2,258 Added 27.73%
10,400 $1.62 Million
Q2 2023

Aug 07, 2023

BUY
$154.35 - $166.11 $254,523 - $273,915
1,649 Added 25.4%
8,142 $1.35 Million
Q1 2023

May 08, 2023

SELL
$151.05 - $180.26 $387,141 - $462,006
-2,563 Reduced 28.3%
6,493 $1.01 Million
Q4 2022

Feb 08, 2023

BUY
$160.2 - $179.79 $278,427 - $312,475
1,738 Added 23.75%
9,056 $1.6 Million
Q3 2022

Nov 07, 2022

SELL
$161.33 - $179.52 $874,892 - $973,536
-5,423 Reduced 42.56%
7,318 $1.2 Million
Q2 2022

Aug 08, 2022

SELL
$168.19 - $186.01 $150,025 - $165,920
-892 Reduced 6.54%
12,741 $2.26 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $756,699 - $859,338
-4,785 Reduced 25.98%
13,633 $2.42 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $48,806 - $54,152
-313 Reduced 1.67%
18,418 $3.15 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $50,549 - $56,174
313 Added 1.7%
18,731 $3.03 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $272,072 - $291,845
1,706 Added 10.21%
18,418 $3.03 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $1.46 Million - $1.63 Million
9,548 Added 133.28%
16,712 $2.75 Million
Q4 2020

Feb 09, 2021

SELL
$137.11 - $157.38 $117,914 - $135,346
-860 Reduced 10.72%
7,164 $1.13 Million
Q3 2020

Nov 16, 2020

BUY
$140.38 - $153.83 $1.13 Million - $1.23 Million
8,024 New
8,024 $1.2 Million
Q2 2020

Aug 10, 2020

SELL
$128.81 - $155.51 $732,156 - $883,918
-5,684 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$111.14 - $153.99 $1.96 Million - $2.71 Million
-17,611 Reduced 75.6%
5,684 $745,000
Q4 2019

Jan 27, 2020

SELL
$127.5 - $146.44 $1.3 Million - $1.5 Million
-10,221 Reduced 30.5%
23,295 $3.4 Million
Q3 2019

Oct 29, 2019

SELL
$126.95 - $142.14 $1.47 Million - $1.64 Million
-11,544 Reduced 25.62%
33,516 $4.34 Million
Q2 2019

Jul 23, 2019

BUY
$131.15 - $144.24 $5.91 Million - $6.5 Million
45,060 New
45,060 $6.28 Million
Q4 2017

Feb 13, 2018

SELL
$131.22 - $143.62 $16.2 Million - $17.7 Million
-123,359 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $194,852 - $203,746
1,505 Added 1.24%
123,359 $16 Million
Q2 2017

Sep 12, 2017

BUY
N/A
121,854
121,854 $16.1 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Donoghue Forlines LLC Portfolio

Follow Donoghue Forlines LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donoghue Forlines LLC with notifications on news.